{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:40:38Z","timestamp":1788698438344,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bristol-Myers Squibb and ONO Pharmaceutical Co.Ltd.","award":["No.IM101-552"],"award-info":[{"award-number":["No.IM101-552"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03683-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:54:17Z","timestamp":1763740457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does perioperative discontinuation of anti-rheumatic drugs increase postoperative complications in orthopedic surgery for rheumatoid arthritis?"],"prefix":"10.1186","volume":"27","author":[{"given":"Hiromu","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyoshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Akasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Kanbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Momohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"5","key":"3683_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/annrheumdis-2017-212424","volume":"77","author":"RL Cordtz","year":"2018","unstructured":"Cordtz RL, Hawley S, Prieto-Alhambra D, et al. Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers. Ann Rheum Dis. 2018;77(5):684\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3683_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/mr\/roac042","volume":"33","author":"A Tominaga","year":"2023","unstructured":"Tominaga A, Ikari K, Yano K, et al. Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: a single-centre, 20-year observational cohort study. Mod Rheumatol. 2023;33(3):509\u201316.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3683_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3899\/jrheum.190182","volume":"47","author":"M Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a M, Quir\u00f3s-Donate J, P\u00e9rez Fern\u00e1ndez E, et al. Orthopedic surgery in rheumatoid arthritis: results from the Spanish National registry of hospitalized patients over 17 years. J Rheumatol. 2020;47(3):341\u20138.","journal-title":"J Rheumatol"},{"issue":"12","key":"3683_CR4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/1756-185X.13974","volume":"23","author":"A Nakajima","year":"2020","unstructured":"Nakajima A, Sakai R, Inoue E, Harigai M. Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National database of health insurance claims and specific health checkups of Japan. Int J Rheum Dis. 2020;23(12):1676\u201384.","journal-title":"Int J Rheum Dis"},{"issue":"9990","key":"3683_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","volume":"386","author":"JA Singh","year":"2015","unstructured":"Singh JA, Cameron C, Noorbaloochi S, et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015;386(9990):258\u201365.","journal-title":"Lancet"},{"issue":"2","key":"3683_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/14397595.2021.1913824","volume":"32","author":"H Ito","year":"2022","unstructured":"Ito H, Murata K, Sobue Y, et al. Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan college of rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Mod Rheumatol. 2022;32(2):296\u2013306.","journal-title":"Mod Rheumatol"},{"issue":"9","key":"3683_CR7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/acr.24893","volume":"74","author":"SM Goodman","year":"2022","unstructured":"Goodman SM, Springer BD, Chen AF, et al. 2022 American college of Rheumatology\/American association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care Res (Hoboken). 2022;74(9):1399\u2013408.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3683_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/mr\/roac019","volume":"33","author":"H Ito","year":"2023","unstructured":"Ito H, Nishida K, Kojima T, et al. Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan college of rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication. Mod Rheumatol. 2023;33(1):36\u201345.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"3683_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jbspin.2015.10.019","volume":"83","author":"M Clay","year":"2016","unstructured":"Clay M, Mazouyes A, Gilson M, Gaudin P, Baillet A. Risk of postoperative infections and the discontinuation of TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2016;83(6):701\u20135.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"3683_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3899\/jrheum.181100","volume":"47","author":"H Ito","year":"2020","unstructured":"Ito H, Tsuji S, Nakayama M, et al. Does abatacept increase postoperative adverse events in rheumatoid arthritis compared with conventional synthetic disease-modifying drugs? J Rheumatol. 2020;47(4):502\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"3683_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/14397595.2015.1071456","volume":"26","author":"K Yano","year":"2016","unstructured":"Yano K, Ikari K, Takatsuki Y, Taniguchi A, Yamanaka H, Momohara S. Longer operative time is the risk for delayed wound healing after forefoot surgery in patients with rheumatoid arthritis. Mod Rheumatol. 2016;26(2):211\u20135.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3683_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5312\/wjo.v5.i3.283","volume":"5","author":"ML Krause","year":"2014","unstructured":"Krause ML, Matteson EL. Perioperative management of the patient with rheumatoid arthritis. World J Orthop. 2014;5(3):283\u201391.","journal-title":"World J Orthop"},{"issue":"4","key":"3683_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhsa.2021.09.038","volume":"47","author":"AM Hresko","year":"2022","unstructured":"Hresko AM, Got CJ, Gil JA. Perioperative management of immunosuppressive medications for rheumatoidarthritis. J Hand Surg Am. 2022;47(4):370\u20138.","journal-title":"J Hand Surg Am"},{"key":"3683_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.knee.2022.12.017","volume":"41","author":"K Vasavada","year":"2023","unstructured":"Vasavada K, Shankar DS, Avila A, Lin CC, Marulanda D, Jazrawi LM, et al. Postoperative flares and peri-arthroscopic management of immunosuppressive medications in patients with rheumatic disease. Knee. 2023;41:171\u20139.","journal-title":"Knee"},{"issue":"1","key":"3683_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02153-x","volume":"11","author":"HK Chung","year":"2021","unstructured":"Chung HK, Wen SH, Chang WC, Liu KL. Acute surgical site infection after total knee arthroplasty in patients with rheumatoid arthritis versus osteoarthritis. Sci Rep. 2021;11(1):22704.","journal-title":"Sci Rep"},{"issue":"4","key":"3683_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40744-020-00238-z","volume":"7","author":"O Taylor-Williams","year":"2020","unstructured":"Taylor-Williams O, Nossent J, Inderjeeth CA. Incidence and complication rates for total hip arthroplasty in rheumatoidarthritis: a systematic review and meta-analysis across four decades. Rheumatol Ther. 2020;7(4):685\u2013702.","journal-title":"Rheumatol Ther"},{"issue":"2","key":"3683_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00296-014-3121-0","volume":"35","author":"Z Abou Zahr","year":"2015","unstructured":"Abou Zahr Z, Spiegelman A, Cantu M, Ng B. Perioperative use of anti-rheumatic agents does not increase early postoperative infection risks: a veteran affairs\u2019 administrative database study. Rheumatol Int. 2015;35(2):265\u201372.","journal-title":"Rheumatol Int"},{"issue":"2","key":"3683_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/mr\/roae089","volume":"35","author":"Y Kiso","year":"2025","unstructured":"Kiso Y, Nishida K, Harada R, et al. The use of biologic disease-modifying antirheumatic drugs does not increase surgical site infection or delayed wound healing after orthopaedic surgeries for rheumatoid arthritis. Mod Rheumatol. 2025;35(2):265\u201372.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3683_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/mr\/road047","volume":"34","author":"K Nishida","year":"2024","unstructured":"Nishida K, Harada R, Nasu Y, et al. Influence of janus kinase inhibitors on early postoperative complications in patients with rheumatoid arthritis undergoing orthopaedic surgeries. Mod Rheumatol. 2024;34(3):466\u201373.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3683_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/s10165-012-0683-0","volume":"23","author":"S Momohara","year":"2013","unstructured":"Momohara S, Hashimoto J, Tsuboi H, et al. Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with Tocilizumab in a real-world setting: results from the multicentre TOPP study. Mod Rheumatol. 2013;23(3):440\u20139.","journal-title":"Mod Rheumatol"},{"issue":"9","key":"3683_CR21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/acr.23843","volume":"71","author":"MD George","year":"2019","unstructured":"George MD, Baker JF, Winthrop K, et al. Timing of abatacept before elective arthroplasty and risk of postoperative outcomes. Arthritis Care Res Hoboken. 2019;71(9):1224\u201333.","journal-title":"Arthritis Care Res Hoboken"},{"issue":"12","key":"3683_CR22","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/acr.23209","volume":"69","author":"MD George","year":"2017","unstructured":"George MD, Baker JF, Winthrop K, et al. Perioperative timing of Infliximab and the risk of serious infection after elective hip and knee arthroplasty. Arthritis Care Res (Hoboken). 2017;69(12):1845\u201354.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"3683_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3899\/jrheum.170366","volume":"45","author":"SM Goodman","year":"2018","unstructured":"Goodman SM, Bykerk VP, DiCarlo E, et al. Flares in patients with rheumatoid arthritis after total hip and total knee arthroplasty: Rates, Characteristics, and risk factors. J Rheumatol. 2018;45(5):604\u201311.","journal-title":"J Rheumatol"},{"issue":"3","key":"3683_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/14397595.2020.1790138","volume":"31","author":"S Okita","year":"2021","unstructured":"Okita S, Ishikawa H, Abe A, et al. Risk factors of postoperative delayed wound healing in patients with rheumatoid arthritis treated with a biological agent. Mod Rheumatol. 2021;31(3):587\u201392.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"3683_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/00016470052943838","volume":"71","author":"SA Lie","year":"2000","unstructured":"Lie SA, Engesaeter LB, Havelin LI, Gjessing HK, Vollset SE. Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian arthroplasty register. Acta Orthop Scand. 2000;71(1):19\u201327.","journal-title":"Acta Orthop Scand"},{"issue":"3","key":"3683_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.arth.2024.08.052","volume":"40","author":"T Karlidag","year":"2025","unstructured":"Karlidag T, Budin M, Luo TD, Dasci MF, Gehrke T, Citak M. What factors influence in-hospital mortality following aseptic revision total hip arthroplasty? A single-center analysis of 13,203 patients. J Arthroplasty. 2025;40(3):744\u201350.","journal-title":"J Arthroplasty"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03683-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:54:17Z","timestamp":1763740457000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03683-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3683"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03683-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective multicenter cohort study received approval from the Ethics Committee of Kyoto University Graduate School and Faculty of Medicine (No.R0053) and the ethics committees of all participating institutions. Because this is a retrospective cohort study, patient\u2019s written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"TM has received speaker fees from AbbVie, Asahi Kasei, Bristol-Myers, Eisai, Eli Lilly, Mochida, and Pfizer. KE also holds the post of the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, which is supported by Asahi-Kasei. KE has received research grants from Asahi-Kasei and Teijin Pharma. KE has received a speaker fee from AbbVie, Amgen, Argenx, Asahi-Kasei, Astellas, Ayumi, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Janssen, Mitsubishi-Tanabe, Ono Pharmaceutical, Pfizer, Sanofi, Taisho, Teijin Pharma, and UCB Japan. RH has received speaker fees from AbbVie G.K., Asahi Kasei Pharma Co., Eisai Co., Ltd and Eli Lilly Japan. TM has received research support from AbbVie GK, Mochida Pharmaceutical Plant Co., Ltd., Nippon Zenyaku Kogyo Co., Ltd.and Gilead Sciences K.K. SM has received consulting\/speakers\u2019 fees and\/or honoraria from AbbVie GK, Eisai Co., Ltd., Eli Lilly Japan K.K., and Gilead Sciences K.K. The other authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}